Key Takeaways
- Abstrax discovers numerous new exotic flavor and aroma compounds in cannabis in collaboration with 710 Labs, SepSolve Analytical, and Markes International.
- Research suggests terpenes don't necessarily distinguish between many cannabis varieties with distinct scents.
- The discovery will aid in validating cannabis authenticity and classification in the future. Abstrax partners with Weedmaps to share these findings and launch an educational content series.
Tustin, CA--Abstrax, in conjunction with experts from 710 Labs, SepSolve Analytical, and Markes International, has unveiled a variety of previously unidentified exotic aroma compounds in cannabis.
[Image via Business Wire]
This research could redefine our comprehension of cannabis' most enticing aromas and their potential entourage effect.
TJ Martin, Vice President of R&D at Abstrax, said in a BusinessWire release that they have found clear correlations between key minor compounds never before seen in cannabis that produce some of the most desirable aromas.
The initial phase of the research involved a human sensory panel evaluating the aroma of multiple ice hash rosin samples.
The results displayed distinct differences between the cannabis varieties.
Following this, advanced 2-dimensional gas chromatography was used to detect hidden compounds that might impact odor.
The study identified various aroma classes responsible for desirable qualities in modern cannabis.
Two classes include tropical Volatile Sulfur Compounds (VSCs) and the heterocyclic compounds Indole and Skatole.
Max Koby, CEO and Co-Founder of Abstrax, added, “This research is important for consumers, researchers, brands, cultivators, labs, regulators, and everyone in between.”
Potential Mislabeling and Quality Assurance
Using the discovered compounds can aid in accurately classifying cannabis varieties.
For instance, Gorilla Glue, known for its distinct chemical scent, was perceived as tropical and citrusy by the sensory panel.
Chemical analysis confirmed these findings, pointing to possible mislabeling.
Brad Melshenker, Co-CEO of 710 Labs, stated, "This research helps us better understand flavor in the cannabis experience, allowing us to better educate our customers and select phenos for our genetic library."
Future Applications and Hope
Iain Oswald, PhD, Abstrax's Principal Research Scientist, believes this discovery can lead to a better understanding of cannabis and its potential therapeutic benefits.
Kevin Koby, Abstrax's Chief Science Officer, emphasized the new possibilities this research can open up for cannabis.
To help disseminate these findings, Abstrax plans to release four white papers for a broader audience.
Pioneering Discoveries and Collaborations
As Abstrax delves deeper into the complexities of cannabis, the company remains dedicated to advancing the industry and enhancing the consumer experience.
According to a Market Screener report, in light of these discoveries, Abstrax has collaborated with Weedmaps.
Together, they aim to launch an educational content series based on Abstrax's groundbreaking findings.
What Do We Think
Abstrax's breakthrough discoveries, combined with its collaboration with Weedmaps, signifies a monumental step forward in understanding cannabis on a molecular level.
The unveiling of these new compounds not only paves the way for a deeper appreciation of cannabis aromas but also provides tools for ensuring product authenticity.
As the industry progresses, it's collaborations like these that will continue to shed light on the multifaceted nature of cannabis and its potential benefits.